Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to estimate the progression-free survival (PFS) for the combination of pemetrexed plus cisplatin plus cetuximab followed by optional pemetrexed plus cetuximab maintenance therapy.
Inclusion criteria
- Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck